Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?
Antibody to capsular polysaccharide has been the basis of several vaccines that offer protection against invasive disease from Streptococcus pneumoniae. The success of such vaccines has led to the inference that natural protection against invasive pneumococcal disease is largely conferred by anticap...
Main Authors: | Marc Lipsitch, Cynthia G Whitney, Elizabeth Zell, Tarja Kaijalainen, Ron Dagan, Richard Malley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2005-01-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC545206?pdf=render |
Similar Items
-
Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection
by: Elizabeth Diago-Navarro, et al.
Published: (2018-04-01) -
Anticapsular and Antifungal Activity of α-Cyperone
by: Connor Horn, et al.
Published: (2021-01-01) -
Erratum for Diago-Navarro et al., “Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection”
by: Elizabeth Diago-Navarro, et al.
Published: (2018-06-01) -
Seasonal Patterns of Invasive Pneumococcal Disease
by: Scott F. Dowell, et al.
Published: (2003-05-01) -
Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
by: Sara Tomczyk, et al.
Published: (2018-04-01)